Market revenue in 2023 | USD 1,059.5 million |
Market revenue in 2030 | USD 1,612.5 million |
Growth rate | 6.2% (CAGR from 2023 to 2030) |
Largest segment | Consulting |
Fastest growing segment | Training & Education |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consulting, Regulatory Affairs, Product Design & Development, Auditing and Assessment, Product Maintenance, Training & Education |
Key market players worldwide | PAREXEL, IQVIA Holdings Inc, Heidelberg Materials AG, Labcorp Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Syneos Health, Lonza Group Ltd, Catalent Inc, Samsung BioLogics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biotechnology and pharmaceutical services outsourcing market will help companies and investors design strategic landscapes.
Consulting was the largest segment with a revenue share of 32.53% in 2023. Horizon Databook has segmented the South Korea biotechnology and pharmaceutical services outsourcing market based on consulting, regulatory affairs, product design & development, auditing and assessment, product maintenance, training & education covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is one of the major pharmaceutical & biotechnology services outsourcing markets. The country is positioned as the world’s 10th largest pharmaceutical market, a significant driver for the country’s prospective economic expansion.
The government has actively promoted local manufacturing of medicines, increasing the number of domestic pharmaceutical companies in the market. This governmental support is anticipated to propel the growth of the domestic pharmaceutical industry.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea biotechnology and pharmaceutical services outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into South Korea biotechnology and pharmaceutical services outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account